DMAC vs FTNT · $157.4M cap vs P/E 56, rev $6.80B
DiaMedica Therapeutics Inc (DMAC) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
DMAC does not have a complete income-statement cache yet.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
DMAC currently screens at market cap $157.4M. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the DMAC and FTNT stock pages for the full models.
Not investment advice.